A PD Solution to Protect Peritoneal Membranes
PD-protec® by Zytoprotec, which now has FDA orphan drug status, is in Phase III trials among 300 patients in the US and Europe. The product aims to reduce PD complications such as peritonitis and membrane failure.
Read the full article » | Posted 01/11/2018
Related Articles
- AWAK PD Attracts Funding Posted 01/09/2020
- PD to Go, Please Posted 12/10/2019
- Portable, Wearable Dialysis—from Russia With Love Posted 12/10/2019
- Fresenius-licensed Endexo Smart Polymer Gets FDA Breakthrough Status to Prevent Clots Posted 11/16/2019
- Diality is Moving Forward with Portable Home HD Posted 11/16/2019